Kyverna Therapeutics, Inc. (KYTX) Earnings Call Transcripts

6 earnings calls from January 2025 to September 24, 2026

NasdaqGS US Health Care Biotechnology

About Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc. (KYTX) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NasdaqGS and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 6 calls on record spanning January 14, 2025 to September 24, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 6 Kyverna Therapeutics, Inc. earnings call transcripts on record, spanning January 14, 2025 to September 24, 2026. Based on this history, Kyverna Therapeutics, Inc. reports semi-annually. The most recent call on file is dated September 24, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
KYTX
Exchange
NasdaqGS
Country
US
Sector
Health Care
Industry
Biotechnology
Calls on record
6
First call
January 14, 2025
Most recent
September 24, 2026
Reporting cadence
semi-annually
Quarter Date
Special Calls Sep 24, 2026 Read transcript →
Company Conference Presentations Sep 14, 2026 Read transcript →
Company Conference Presentations Mar 9, 2026 Read transcript →
Company Conference Presentations Jan 14, 2026 Read transcript →
Special Calls Dec 15, 2025 Read transcript →
Company Conference Presentations Jan 14, 2025 Read transcript →